Activity in US debt capital markets is poised to be focused on the leveraged-loan and structured-finance segments Thursday as corporate-bond issuance remain scant amid the government shutdown and the start of earnings season.
- Just over a dozen loan transactions have lender commitments due
- Six of them are over $1 billion in size, led by the dual-currency repricings at former Sanofi consumer-health arm Opella
- At least four deals are poised to price Thursday in the US ABS market, after
eight did so on Wednesday and as the pipeline for coming deals continues to fill - Meanwhile, no
investment-grade orhigh-yield corporate bonds ...